- Home
- LFCR vs OABI Comparison
LFCR vs OABI Comparison
Compare LFCR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- OABI
- Stock Information
- Founded
- LFCR 1986
- OABI 2012
- Country
- LFCR United States
- OABI United States
- Employees
- LFCR N/A
- OABI N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- LFCR Health Care
- OABI Health Care
- Exchange
- LFCR Nasdaq
- OABI Nasdaq
- Market Cap
- LFCR 308.8M
- OABI 250.8M
- IPO Year
- LFCR N/A
- OABI N/A
- Fundamental
- Price
- LFCR $7.50
- OABI $2.17
- Analyst Decision
- LFCR Buy
- OABI Strong Buy
- Analyst Count
- LFCR 4
- OABI 3
- Target Price
- LFCR $8.00
- OABI $7.00
- AVG Volume (30 Days)
- LFCR 224.3K
- OABI 623.5K
- Earning Date
- LFCR 08-25-2025
- OABI 08-06-2025
- Dividend Yield
- LFCR N/A
- OABI N/A
- EPS Growth
- LFCR N/A
- OABI N/A
- EPS
- LFCR N/A
- OABI N/A
- Revenue
- LFCR $130,309,000.00
- OABI $26,744,000.00
- Revenue This Year
- LFCR $1.64
- OABI N/A
- Revenue Next Year
- LFCR $2.91
- OABI $45.02
- P/E Ratio
- LFCR N/A
- OABI N/A
- Revenue Growth
- LFCR 7.23
- OABI 27.07
- 52 Week Low
- LFCR $3.68
- OABI $1.22
- 52 Week High
- LFCR $8.85
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- LFCR 45.04
- OABI 64.53
- Support Level
- LFCR $7.39
- OABI $1.90
- Resistance Level
- LFCR $7.67
- OABI $2.11
- Average True Range (ATR)
- LFCR 0.35
- OABI 0.14
- MACD
- LFCR -0.13
- OABI -0.00
- Stochastic Oscillator
- LFCR 4.79
- OABI 62.38
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.